Value of heparin-binding protein in ascites and serum procalcitonin in diagnosis of spontaneous bacterial peritonitis

Yang LiXia; Zhang LunLi; Lai LingLing; Fang Ming

doi:10.3969/j.issn.1001-5256.2019.06.017

Volume 35 Issue 6

Jun. 2019

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2019 > 35(6): 1266-1269

PDF( 2124 KB)

Value of heparin-binding protein in ascites and serum procalcitonin in diagnosis of spontaneous bacterial peritonitis

DOI: 10.3969/j.issn.1001-5256.2019.06.017

Department of Infectious Diseases, The First Affiliated Hospital of Nanchang University

Research funding:

Received Date: 2018-12-27
Published Date: 2019-06-20

Abstract

Abstract

Objective To investigate the value of heparin-binding protein (HBP) in ascites combined with serum procalcitonin (PCT) in the diagnosis of spontaneous bacterial peritonitis (SBP) . Methods A total of 120 patients with ascites who were hospitalized in our hospital from January 2016 to June 2018 were enrolled and divided into cirrhotic ascites + SBP group with 40 patients, leaky ascites group with 40 patients, malignant ascites group with 20 patients, and tuberculous ascites group with 20 patients. Bacterial culture of ascites was performed for all patients, and polymorphonuclear leukocyte (PMN) count in ascites, HBP in ascites, and serum PCT level were measured and analyzed.The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and an analysis of variance was used for comparison between multiple groups; non-normally distributed continuous data were expressed as median [M (P25, P75) ], and the Kruskal-Wallis H test was used for comparison between multiple groups and the Nemenyi test was used for comparison between two groups. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic efficiency of HBP in ascites and serum PCT, and the Spearman correlation analysis was used to investigate the correlation between HBP in ascites and serum PCT. Results The cirrhotic ascites + SBP group had significant increases in the levels of HBP in ascites and serum PCT compared with the leaky ascites group, the malignant ascites group, and the tuberculous ascites group (P < 0. 05) . There was no significant difference in HBP level in ascites between patients with different bacteria determined by bacterial culture of ascites (P > 0. 05) , and there was also no significant difference in HBP level in ascites between patients with positive or negative results of bacterial culture of ascites (58. 59 ± 36. 23 ng/ml vs 63. 61 ±32. 54 ng/ml, t = 1. 763, P > 0. 05) . Serum PCT had an optimal cut-off value of 0. 62 ng/ml in the diagnosis of SBP, with an area under the ROC curve of 0. 831, a sensitivity of 86. 3%, and a specificity of 52. 8%. HBP in ascites had an optimal cut-off value of 23. 54 ng/ml in the diagnosis of SBP, with an area under the ROC curve of 0. 962, a sensitivity of 92. 3%, and a specificity of 65. 4%. Ascites HBP was highly correlated with serum PCT (r = 0. 776, P < 0. 05) . Conclusion The level of HBP in ascites has a high value in the diagnosis of SBP, and combined measurement of ascites HBP and serum PCT can improve the diagnostic efficiency of SBP.
- liver cirrhosis,
- spontaneous bacterial peritonitis,
- ascites,
- heparin binding protein,
- procalcitonin

FullText(HTML)

References(16)

References

[1]TVERRING J, VAARA SUVI T, FISHER J, et al.Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury[J].Ann Intensive Care, 2017, 7 (1) :105.

[2]KIM JJ, TSUKAMOTO MM, MATHUR AK, et al.Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis[J].Am J Gastroenterol, 2014, 109 (9) :1436-1442.

[3]MEHRNAZ AG, SEYED FA, HOSSEIN F, et al.Blood Procalcitonin predicts spontaneous bacterial peritonitis in patients with cirrhosis and ascites[J].Middle East J Dig Dis, 2015, 7:189-190.

[4]McLAUGHLIN D, SHELLENBACK L.Sepsis in patients with cirrhosis[J].AACN Adv Crit Care, 2016, 27 (4) :408-419.

[5]RHODES A, EVANS LE, ALHAZZANI W, et al.Surviving sepsis campaign:International guidelines for management of sepsis and septic shock:2016[J].Intensive Care Med, 2017, 43 (3) :304-377.

[6]European Association for the Study of Liver.EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J].JHepatol, 2010, 53 (3) :397-417.

[7]GOMEZ-CERQUERA JM, DAROCA-PREZ R, BAEZA-TRINIDAD R, et al.Validity of procalcitonin for the diagnosis of bacterial infection in elderly patients[J].Enferm Infecc Microbiol Clin, 2015, 33 (8) :521-524.

[8]YU W, CHENG YF, ZHANG R.Changes and significance of BNP, NT-proBNP, PCT, NT-proBNP/BNP ratio in elderly patients with heart failure complicated with pulmonary infection[J].Sichuan Med J, 2017, 38 (11) :1314-1317. (in Chinese) 余微, 程幼夫, 张汝.老年心力衰竭合并肺部感染患者BNP、NT-proBNP、PCT、NT-proBNP/BNP比值水平变化及意义[J].四川医学, 2017, 38 (11) :1314-1317.

[9]WANG CM, MENG ZJ, CHEN Y, et al.Value of serum PCT in early diagnosis of bacterial infection in patients with liver failure[J].J Clin Hepatol, 2017, 33 (6) :1137-1138. (in Chinese) 王传敏, 孟忠吉, 陈悦, 等.血清降钙素原检测对肝衰竭合并感染的早期诊断价值[J].临床肝胆病杂志, 2017, 33 (6) :1137-1138.

[10]LIU F, LONG WD, ZHU GM, et al.The values of PCT and CRP in the diagnosis and prognosis of spontaneous bacterial peritonitis in patients with advanced liver disease[J].Chin J Gastroenterol Hepatol, 2017, 26 (9) :1030-1032. (in Chinese) 刘锋, 隆维东, 朱艮苗, 等.PCT及CRP对晚期肝病自发性细菌性腹膜炎患者的诊断及预后价值分析[J].胃肠病学和肝病学杂志, 2017, 26 (9) :1030-1032.

[11]FISHER J, LINDER A.Heparin-binding protein:A key player in the pathophysiology of organ dysfunction in sepsis[J].J Intern Med, 2017, 281 (6) :562-574.

[12]ZHU L, OLSEN RJ, RANDALL J, et al.Contribution of secreted NADase and streptolysin O to the pathogenesis of epidemic serotype M1 streptococcus pyogenes infections[J].Am JPathol, 2017, 187 (3) :605-613.

[13]SNALL J, LINNER A, UHLMANN J, et al.Differential neutrophil responses to bacterial stimuli:Streptococcal strains are potent inducers of heparin-binding protein and resistin-release[J].Sci Rep, 2016, 6:21288.

[14]KASUS-JACOBI A, NOOR-MOHAMMADI S, GRIFFITH G, et al.A multifunctional peptide based on the neutrophil immune defense molecule, CAP37 has antibacterial and woundhealing properties[J].J Leukoc Biol, 2015, 97 (2) :341-350.

[15]LINDER A, KESSON P, INGHAMMAR M, et al.Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock[J].Crit Care, 2012, 16 (3) :90.

[16]LINDER A, RYAN A, JOHN B, et al.Heparin-binding protein measurement improves the prediction of severe infection with organ dysfunction in the emergency department[J].Crit Care Med, 2015, 43 (11) :2378-2386.

Relative Articles

[1]	Gao ShengLi, Zhao Gang, Xu MiQin, Shen Yan, Yu Jing, Ye Yang, He LiHua, Jin WenJuan, Sun GuiYing, Niu ZhiLin. Efficacy and safety of interferon-α given additionally or sequentially after long-term entecavir therapy in treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2018, 34(2): 268-271. doi: 10.3969/j.issn.1001-5256.2018.02.010
[2]	Tao JunXiu, Li XiaoDong, Cao Ting, Xiao MingZhong, Wu HuiKun, Wu Deng, Ren Meng, Wang Ting, Bai LiYing. A study of compliance in patients with HBeAg-negative chronic hepatitis B receiving entecavir treatment[J]. Journal of Clinical Hepatology, 2017, 33(8): 1558-1560. doi: 10.3969/j.issn.1001-5256.2017.08.030
[3]	Wu YanQin, Shen LiJun, Yu JiHong, Sun YuShan. Clinical effect of entecavir in treatment of chronic hepatitis B complicated by hepatic steatosis[J]. Journal of Clinical Hepatology, 2017, 33(5): 849-852. doi: 10.3969/j.issn.1001-5256.2017.05.011
[4]	Li Na, Gou Wei, Cui WeiLi. Efficacy of telbivudine combined with adefovir dipivoxil and pegylated interferon combined with entecavir as antiviral therapy for chronic hepatitis B: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(9): 1714-1716. doi: 10.3969/j.issn.1001-5256.2016.09.015
[5]	Huang Ling, Ning HuiMing, Xu YanHua, Tang Qun, Ou Qiang. Clinical effect of entecavir combined with thymosin in treatment of HBe Ag-positive hepatitis B patients[J]. Journal of Clinical Hepatology, 2016, 32(11): 2070-2074. doi: 10.3969/j.issn.1001-5256.2016.11.011
[6]	Xie YongCai, Hu GuoXin, Peng YanZhong, Zheng Jie, Li YinPing. Clinical effect of Dahuang Zhechong capsules combined with entecavir in treatment of chronic hepatitis B patients with liver fibrosis[J]. Journal of Clinical Hepatology, 2016, 32(8): 1502-1507. doi: 10.3969/j.issn.1001-5256.2016.08.014
[7]	Han BenLi. Clinical efficacy of entecavir in HBeAg-negative chronic hepatitis B with compensated cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(8): 1525-1528. doi: 10.3969/j.issn.1001-5256.2016.08.018
[8]	Zhu DongLiang, Li DaoBo, Zhao ManZhi, Ma Ke, Song JianXin, Xu Dong. Clinical effect of entecavir in treatment of patients with chronic hepatitis B complicated by tuberculosis[J]. Journal of Clinical Hepatology, 2016, 32(11): 2084-2087. doi: 10.3969/j.issn.1001-5256.2016.11.014
[9]	Wang He, Wang QianJun, Sun FengBo, Zhang XinMing, Qi YuQin. Effect of entecavir combined with Fuzheng Huayu capsules on inflammatory factors and fibrosis markers in patients with compensated chronic hepatitis B-related cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(9): 1734-1738. doi: 10.3969/j.issn.1001-5256.2016.09.020
[10]	Xia ShuLin, He XiaoFeng. Efficacy of entecavir treatment for patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(4): 523-525. doi: 10.3969/j.issn.1001-5256.2015.04.011
[11]	Zhang Wen, Yu JianGuo, Zhu GuiZhong, Zhao ZhanDong, Wang XiaoWei. Clinical efficacy of entecavir combined with adefovir in chronic hepatitis B patients with high viral load[J]. Journal of Clinical Hepatology, 2014, 30(11): 1169-1172. doi: 10.3969/j.issn.1001-5256.2014.11.019
[12]	Wu LieXiu, Lin ShuMei, Zhang Xi, Zheng ShuQin, Ye Feng, Chen TianYan, Zhao YingRen, Zhang ShuLin. Dynamic changes in B7- H1 expression on peripheral blood mononuclear cells in chronic hepatitis B patients treated with entecavir[J]. Journal of Clinical Hepatology, 2014, 30(9): 929-931. doi: 10.3969/j.issn.1001-5256.2014.09.023
[13]	Gou Wei, Wang YanLing, Zhou Yong, Xun ShuLing. Effects of entecavir on liver fibrosis indices in patients with hepatogenous diabetes[J]. Journal of Clinical Hepatology, 2014, 30(12): 1330-1333. doi: 10.3969/j.issn.1001-5256.2014-12.023
[14]	Gao YuanZheng, Jia SuHua, Zhao LianFeng, Jiang Ying, Wang Yan. Clinical efficacy of entecavir combined with Xinganbao capsules in treatment of liver cirrhosis among patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(4): 314-316. doi: 10.3969/j.issn.1001-5256.2014.04.007
[15]	Gou Wei, Wang YanLing, Xu XiaoWei, Xu WenWei. Clinical efficacy of entecavir in treatment of hepatogenous diabetes [J]. Journal of Clinical Hepatology, 2013, 29(6): 456-458.
[16]	Yan HaiMing, Chen JianHua, Ye YiNong, Long Hui, Wang XiangHuai. Clinical effects of lamivudine combined with adefovir dipivoxil and entecavir alone in 48-week treatment of HBeAg-positive chronic hepatitis B:preliminary comparative study[J]. Journal of Clinical Hepatology, 2013, 29(7): 508-511. doi: 1001-5256 (2013) 07-0508-04
[17]	Chen FangZhi, Li GuoQing, Zhang Li, Liu HongYing. Clinical effect of entecavir in patients with decompensated hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2010, 26(6): 608-609+612.
[18]	Yang YaFang, Yang XiaoPing, Dong JianGuo, Wang ZhiGang, Liu YanPing, Zhao TieJun, Gao Feng. Analysis of short-term efficacy of entecavir and adefovir dipivoxil in the treatment of HBeAg-positive chronic hepatitis B [J]. Journal of Clinical Hepatology, 2010, 26(3): 326-327.
[20]	Yang GuiSheng, Wang HaiTao, Chang AiNa. Study of Entecavir in treating chronic hepatitis B Patients[J]. Journal of Clinical Hepatology, 2007, 23(6): 426-427.

Supplements(0)

Cited By

Cited by

Periodical cited type(2)

1.	任静，李小东，乔丽颖，曹毛毛，席云峰. 内蒙古地区肝癌高危人群筛查模型效果评价. 中国肿瘤. 2022(08): 639-648 .
2.	朱威，黄燕. 肝细胞癌早期筛查的血清生物学标志物研究进展. 中华肝脏病杂志. 2021(04): 308-312 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (1736) PDF downloads(284)

Value of heparin-binding protein in ascites and serum procalcitonin in diagnosis of spontaneous bacterial peritonitis

DOI: 10.3969/j.issn.1001-5256.2019.06.017